Dallas Seitz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dallas Seitz has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
- David F. Tang-Wai
University of Toronto, Temerty Faculty of Medicine, Department of Medicine, Division of Neurology, Toronto ON, Canada
3 shared publications - Gary Naglie
Baycrest Health Sciences, Toronto, ON Canada
3 shared publications - Mario Masellis
L.C. Campbell Cognitive Neurology Research Unit, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
3 shared publications - Mark Jeffrey Rapoport
Department of Psychiatry, Termerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
3 shared publications - Nathan Herrmann
Sunnybrook Research Institute
3 shared publications - Alex Kiss
Institute for Clinical Evaluative Sciences, Toronto, ON, Canada
2 shared publications
Latest Publications
- Open Access
- 30 August 2026
- Published by Wiley in International Journal of Methods in Psychiatric Research
- Vol. 35 (3) , e70105
Comparing Administrative Data and Resident Assessment Instrument Data for Mental Health Surveillance in Home Care and Long‐Term Care Populations
Objectives: To compare mental illness prevalence, and agreement between mental illness measures, in home care (HC) and long‐term care (LTC) using administrative definitions and Resident Assessment Instrument (RAI)‐diagnoses. Methods: Applying a common protocol to linked administrative‐RAI datasets in Alberta, Manitoba, and Ontario, Canada, we selected adults receiving HC or LTC between 2012 and 2023. Cross‐sectionally, we compared administrative definitions with RAI‐diagnoses (depression, anxiety, bipolar disorder and schizophrenia) using kappa, sensitivity, specificity, positive and negative predictive value. We examined discordance‐associated factors using multivariable logistic regression. Results: Depression was the most prevalent mental illness (administrative data, HC: 29%–34% of 493,895 people; LTC: 21%–51% of 357,117 people). Prevalence estimates were consistently lower using RAI‐diagnoses than administrative definitions. Agreement between data sources was moderate for depression ( k = 0.33–0.57) and anxiety disorders ( k = 0.35–0.63). Younger age, dementia, and more physician visits were associated with higher likelihood of discordance between data sources; male sex had a lower likelihood. Conclusion: While mental illness prevalence is high in HC and LTC populations, RAI‐based estimates are lower than administrative data estimates. Discordance between data sources differs by individual characteristics. Concurrent comparison of RAI‐diagnoses and administrative data to a gold standard clinical interview would clarify the optimal surveillance strategy.
- 30 August 2026
- Published by Wiley in International Journal of Methods in Psychiatric Research
- Vol. 35 (3) , e70105
Open AccessComparing Administrative Data and Resident Assessment Instrument Data for Mental Health Surveillance in Home Care and Long‐Term Care Populations
Objectives: To compare mental illness prevalence, and agreement between mental illness measures, in home care (HC) and long‐term care (LTC) using administrative definitions and Resident Assessment Instrument (RAI)‐diagnoses. Methods: Applying a common protocol to linked administrative‐RAI datasets in Alberta, Manitoba, and Ontario, Canada, we selected adults receiving HC or LTC between 2012 and 2023. Cross‐sectionally, we compared administrative definitions with RAI‐diagnoses (depression, anxiety, bipolar disorder and schizophrenia) using kappa, sensitivity, specificity, positive and negative predictive value. We examined discordance‐associated factors using multivariable logistic regression. Results: Depression was the most prevalent mental illness (administrative data, HC: 29%–34% of 493,895 people; LTC: 21%–51% of 357,117 people). Prevalence estimates were consistently lower using RAI‐diagnoses than administrative definitions. Agreement between data sources was moderate for depression ( k = 0.33–0.57) and anxiety disorders ( k = 0.35–0.63). Younger age, dementia, and more physician visits were associated with higher likelihood of discordance between data sources; male sex had a lower likelihood. Conclusion: While mental illness prevalence is high in HC and LTC populations, RAI‐based estimates are lower than administrative data estimates. Discordance between data sources differs by individual characteristics. Concurrent comparison of RAI‐diagnoses and administrative data to a gold standard clinical interview would clarify the optimal surveillance strategy.
- 31 December 2025
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 74 (3) , 633-635
Comparative Safety of Medications for Severe Agitation: Lessons Learned From Management of Behavioral and Psychological Symptoms of Dementia
- 31 December 2025
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 74 (3) , 633-635
Comparative Safety of Medications for Severe Agitation: Lessons Learned From Management of Behavioral and Psychological Symptoms of Dementia
- Open Access
- 9 April 2025
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 26 (6) , 105567
Fall Risk–Increasing Drugs and Fall-Related Injuries among Older Adults in Ontario: A Population-Based Matched Case-Control Study
- 9 April 2025
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 26 (6) , 105567
Open AccessFall Risk–Increasing Drugs and Fall-Related Injuries among Older Adults in Ontario: A Population-Based Matched Case-Control Study
- 8 April 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 104 (7) , e213438
Association of Plasma Biomarkers With Longitudinal Atrophy and Microvascular Burden on MRI Across Neurodegenerative and Cerebrovascular Diseases
Plasma biomarkers of Alzheimer disease (AD), neuroinflammation, and neurodegeneration are increasingly being used in clinical trials for diagnosis and monitoring of dementia. However, their association with longitudinal structural brain MRI changes, an important outcome measure across neurodegenerative and cerebrovascular diseases, is less known. We investigated how baseline plasma biomarkers reflect MRI markers of progression over time in patients with neurodegenerative and cerebrovascular diseases. This longitudinal cohort study included patients from the Ontario Neurodegenerative Disease Research Initiative diagnosed with AD or mild cognitive impairment (AD/MCI), Parkinson disease (PD), frontotemporal dementia spectrum disorders (FTD), or cerebrovascular disease (CVD), followed annually for 2 years. Recruitment took place at specialized university-based dementia, movement disorders, and/or stroke clinics in the province of ON, Canada. MRI outcomes included markers of cerebral atrophy (ventricular CSF and regional gray matter volumes) and of small vessel disease pathology (white matter hyperintensity [WMH], perivascular spaces, and lacunar volumes). Hemorrhagic markers at baseline were also included. Plasma levels of glial fibrillary acidic protein (GFAP), neurofilament light chain (NfL), phosphorylated tau181 and tau217 (p-tau181, p-tau217), and β-amyloid (Aβ42/40) were quantified from blood samples collected at baseline using Simoa and used as predictors in linear mixed models adjusted for time (months), age, sex, apolipoprotein E (APOE)-ε4 carrier status, kidney function, vascular risk factors, microtubule-associated protein tau (MAPT) diplotypes, waist-hip circumference ratio, and disease duration. We analyzed 1,240 MRIs from 473 patients (age: 69.2 ± 7.4 [range: 49-87]; 32.8% women). Elevated baseline levels of GFAP, NfL, p-tau181, and p-tau217, and to a lesser extent decreased levels of Aβ42/40, were significantly associated with more cerebral atrophy and WMH burden at baseline (|B| = 0.02 to 1.69, p = 0.044 to B| = 0.001 to 0.028, p = 0.049 to <0.001) in the pooled disease-agnostic group. Within disease-specific cohorts, GFAP and NfL were associated with cerebral atrophy and/or small vessel disease copathology in AD/MCI, PD, FTD, or CVD. P-tau181 and p-tau217 were associated with cerebral atrophy and/or small vessel disease copathology in AD/MCI, CVD, PD-MCI, or PD-dementia. Selected plasma biomarkers seem useful as prognosis and monitoring tools of longitudinal imaging changes within real-world populations of neurodegenerative and/or cerebrovascular diseases, and provide insight into overlap across diseases in shared pathologic burden.
- 8 April 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 104 (7) , e213438
Association of Plasma Biomarkers With Longitudinal Atrophy and Microvascular Burden on MRI Across Neurodegenerative and Cerebrovascular Diseases
Plasma biomarkers of Alzheimer disease (AD), neuroinflammation, and neurodegeneration are increasingly being used in clinical trials for diagnosis and monitoring of dementia. However, their association with longitudinal structural brain MRI changes, an important outcome measure across neurodegenerative and cerebrovascular diseases, is less known. We investigated how baseline plasma biomarkers reflect MRI markers of progression over time in patients with neurodegenerative and cerebrovascular diseases. This longitudinal cohort study included patients from the Ontario Neurodegenerative Disease Research Initiative diagnosed with AD or mild cognitive impairment (AD/MCI), Parkinson disease (PD), frontotemporal dementia spectrum disorders (FTD), or cerebrovascular disease (CVD), followed annually for 2 years. Recruitment took place at specialized university-based dementia, movement disorders, and/or stroke clinics in the province of ON, Canada. MRI outcomes included markers of cerebral atrophy (ventricular CSF and regional gray matter volumes) and of small vessel disease pathology (white matter hyperintensity [WMH], perivascular spaces, and lacunar volumes). Hemorrhagic markers at baseline were also included. Plasma levels of glial fibrillary acidic protein (GFAP), neurofilament light chain (NfL), phosphorylated tau181 and tau217 (p-tau181, p-tau217), and β-amyloid (Aβ42/40) were quantified from blood samples collected at baseline using Simoa and used as predictors in linear mixed models adjusted for time (months), age, sex, apolipoprotein E (APOE)-ε4 carrier status, kidney function, vascular risk factors, microtubule-associated protein tau (MAPT) diplotypes, waist-hip circumference ratio, and disease duration. We analyzed 1,240 MRIs from 473 patients (age: 69.2 ± 7.4 [range: 49-87]; 32.8% women). Elevated baseline levels of GFAP, NfL, p-tau181, and p-tau217, and to a lesser extent decreased levels of Aβ42/40, were significantly associated with more cerebral atrophy and WMH burden at baseline (|B| = 0.02 to 1.69, p = 0.044 to B| = 0.001 to 0.028, p = 0.049 to <0.001) in the pooled disease-agnostic group. Within disease-specific cohorts, GFAP and NfL were associated with cerebral atrophy and/or small vessel disease copathology in AD/MCI, PD, FTD, or CVD. P-tau181 and p-tau217 were associated with cerebral atrophy and/or small vessel disease copathology in AD/MCI, CVD, PD-MCI, or PD-dementia. Selected plasma biomarkers seem useful as prognosis and monitoring tools of longitudinal imaging changes within real-world populations of neurodegenerative and/or cerebrovascular diseases, and provide insight into overlap across diseases in shared pathologic burden.
- Open Access
- 29 May 2024
- Published by JMIR Publications Inc. in JMIR Preprints
The Behaviours in Dementia Toolkit: A descriptive study on the reach and early impact of a digital health resource library about dementia-related mood and behaviour changes (Preprint)
BACKGROUND Dementia is a syndrome with a high global prevalence that includes a number of progressive diseases of the brain affecting various cognitive domains such as memory and thinking, and the performance of daily activities. It manifests as symptoms across a number of domains, which often include significant mood and behaviour changes. Changed moods and behaviours due to dementia may reflect distress, they are highly varied, and may be stressful for both the person living with dementia and their informal and formal carers. To provide dementia care support specific to mood and behaviour changes, the Behaviours in Dementia Toolkit website was developed using human-centered design principles. The Behaviours in Dementia houses a user-friendly, digital library of over 300 free, practical and evidence-informed resources to help all care partners better understand and compassionately respond to behaviours in dementia so they can support people with dementia to live well. OBJECTIVE To determine whether the development and implementation of the Behaviours in Dementia Toolkit was successful in creating website users and to understand the platform’s early impact. METHODS A multi-method, descriptive study was conducted in the early post-launch period to examine reach, engagement, knowledge change, behaviour change, and website impact outcomes and measures via Google Analytics and an electronic survey of website users. RESULTS From February 4 to March 31, 2024 there were 76,890 unique visitors to the Behaviours in Dementia Toolkit from 109 countries. Of 76,890 unique visitors to the Behaviours in Dementia Toolkit during this period, 16,626 were engaged users (21.6%) from 80 countries. The highest number of unique engaged users were from Canada (n=8,124) with an engagement rate of 37.7%. From March 5, 2024 to March 31, 2024, 100 electronic surveys were completed by website users and included in the analysis. Website users indicated that the Toolkit validated or increased their dementia-care knowledge, beliefs, and activities (82.0%) and they reported that the website validated their current care approaches or increased their ability to provide care (78.0%). Further, 77.0% of respondents indicated that they intend to continue using the Toolkit and 81.6% said they would recommend it to others to review and adopt. CONCLUSIONS The Behaviours in Dementia Toolkit is a promising tool for sharing practical and evidence-informed information resources to support people experiencing dementia related mood and behaviour changes. Early evaluation of the website has demonstrated significant reach and engagement with users in Canadian and internationally. Survey data also demonstrated high ratings of website relevance, feasibility, intention to use, knowledge change, practice support, and its contribution to dementia guidance.
- 29 May 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessThe Behaviours in Dementia Toolkit: A descriptive study on the reach and early impact of a digital health resource library about dementia-related mood and behaviour changes (Preprint)
BACKGROUND Dementia is a syndrome with a high global prevalence that includes a number of progressive diseases of the brain affecting various cognitive domains such as memory and thinking, and the performance of daily activities. It manifests as symptoms across a number of domains, which often include significant mood and behaviour changes. Changed moods and behaviours due to dementia may reflect distress, they are highly varied, and may be stressful for both the person living with dementia and their informal and formal carers. To provide dementia care support specific to mood and behaviour changes, the Behaviours in Dementia Toolkit website was developed using human-centered design principles. The Behaviours in Dementia houses a user-friendly, digital library of over 300 free, practical and evidence-informed resources to help all care partners better understand and compassionately respond to behaviours in dementia so they can support people with dementia to live well. OBJECTIVE To determine whether the development and implementation of the Behaviours in Dementia Toolkit was successful in creating website users and to understand the platform’s early impact. METHODS A multi-method, descriptive study was conducted in the early post-launch period to examine reach, engagement, knowledge change, behaviour change, and website impact outcomes and measures via Google Analytics and an electronic survey of website users. RESULTS From February 4 to March 31, 2024 there were 76,890 unique visitors to the Behaviours in Dementia Toolkit from 109 countries. Of 76,890 unique visitors to the Behaviours in Dementia Toolkit during this period, 16,626 were engaged users (21.6%) from 80 countries. The highest number of unique engaged users were from Canada (n=8,124) with an engagement rate of 37.7%. From March 5, 2024 to March 31, 2024, 100 electronic surveys were completed by website users and included in the analysis. Website users indicated that the Toolkit validated or increased their dementia-care knowledge, beliefs, and activities (82.0%) and they reported that the website validated their current care approaches or increased their ability to provide care (78.0%). Further, 77.0% of respondents indicated that they intend to continue using the Toolkit and 81.6% said they would recommend it to others to review and adopt. CONCLUSIONS The Behaviours in Dementia Toolkit is a promising tool for sharing practical and evidence-informed information resources to support people experiencing dementia related mood and behaviour changes. Early evaluation of the website has demonstrated significant reach and engagement with users in Canadian and internationally. Survey data also demonstrated high ratings of website relevance, feasibility, intention to use, knowledge change, practice support, and its contribution to dementia guidance.
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S19)
A Scoping Review of Outdoor Activities for People Living with Dementia
Background: Outdoor or nature‐based activities can potentially offer benefits to improve the quality of life for people living with dementia (PLWD). The aim of this scoping review is to gain a clear understanding of current studies on outdoor activities for PLWD and their caregivers, as well as to identify gaps in the literature that may require further research.Method: We systematically searched the following electronic databases: MEDLINE (Ovid); EMBASE (Ovid); APA PsycINFO (Ovid); CINAHL; Cochrane followed the guidelines recommended by the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses Extension for scoping reviews (PRISMA‐ScR) (Tricco et al., 2018). We included primary studies that met the following criteria:1) the study population includes either PLWD or people self‐identified as caring for people with dementia; 2) study outcomes are related to outdoor activities and/or nature; 3) the study report effects of how the outdoor activities change the diagnosis of dementia either qualitatively and/or quantitatively; 4) primary studies and literature reviews, dissertations, conference presentations or discussion papers, peer reviews and non‐peer reviewed; 6) all geographical areas but published in English and year 1980 to presentResult: Our initial search resulted in 7678 potentially relevant titles and abstracts. This number was decreased to 299 articles for the full‐text review. The extracted data have been charted by the following categories: authors, year of publication, study location, aims/purpose, characteristics of included studies, methods, outcomes, and key findings. The findings were summarized using frequency counts of concepts and characteristics. Thematic analysis was undertaken which identified four themes. More specifically, we identified 1) Benefits of outdoor or nature‐based activities; 2) Interventions to improve quality of life; 3) Barriers and challenges to accessing outdoors and nature; 4) Recommendations for outdoors or nature‐based activities.Conclusion: There is growing evidence for the benefit of outdoor activities, recommendations to improve outdoor activities and which interventions are most beneficial among people with dementia. There is limited information about factors which may act as barriers for people with dementia which will be important to ensure wider access to these activities.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S19)
Open AccessA Scoping Review of Outdoor Activities for People Living with Dementia
Background: Outdoor or nature‐based activities can potentially offer benefits to improve the quality of life for people living with dementia (PLWD). The aim of this scoping review is to gain a clear understanding of current studies on outdoor activities for PLWD and their caregivers, as well as to identify gaps in the literature that may require further research.Method: We systematically searched the following electronic databases: MEDLINE (Ovid); EMBASE (Ovid); APA PsycINFO (Ovid); CINAHL; Cochrane followed the guidelines recommended by the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses Extension for scoping reviews (PRISMA‐ScR) (Tricco et al., 2018). We included primary studies that met the following criteria:1) the study population includes either PLWD or people self‐identified as caring for people with dementia; 2) study outcomes are related to outdoor activities and/or nature; 3) the study report effects of how the outdoor activities change the diagnosis of dementia either qualitatively and/or quantitatively; 4) primary studies and literature reviews, dissertations, conference presentations or discussion papers, peer reviews and non‐peer reviewed; 6) all geographical areas but published in English and year 1980 to presentResult: Our initial search resulted in 7678 potentially relevant titles and abstracts. This number was decreased to 299 articles for the full‐text review. The extracted data have been charted by the following categories: authors, year of publication, study location, aims/purpose, characteristics of included studies, methods, outcomes, and key findings. The findings were summarized using frequency counts of concepts and characteristics. Thematic analysis was undertaken which identified four themes. More specifically, we identified 1) Benefits of outdoor or nature‐based activities; 2) Interventions to improve quality of life; 3) Barriers and challenges to accessing outdoors and nature; 4) Recommendations for outdoors or nature‐based activities.Conclusion: There is growing evidence for the benefit of outdoor activities, recommendations to improve outdoor activities and which interventions are most beneficial among people with dementia. There is limited information about factors which may act as barriers for people with dementia which will be important to ensure wider access to these activities.
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S20)
Experiences of People Living with Dementia and their Care Partners in Participating in Outdoor Activities
Background: There is increasing evidence for non‐pharmacological interventions to prevent dementia and delay disease progression. Outdoor recreational activities, such as visits to local parks, may help improve behavioural symptoms of dementia, cognition, and quality of life for both people living with dementia (PLWD) and their care partners. However, little is currently known about the experiences of PLWD and care partners about participating in outdoor activities. Understanding their experiences will help inform interventions and policies to promote participation in outdoor activities. Our objectives are to understand the experiences of PLWD and care partners in participating in outdoor activities.Methods: We conducted semi‐structured interviews with PLWD and care partners, either alone or in dyads. Self‐reported characteristics of PLWD and care partners were recorded by online surveys. Interviews were recorded and transcribed for analysis. Interview questions included questions about the following topics: individuals relationships to outdoor activities; how these relationships may have changed over time; their current patterns of outdoor activities; perceived benefits of outdoor activities; potential risks of outdoor activities; and facilitators and barriers to participating in activities. The transcripts of interviews were coded by two independent members of the research team to identify common themes.Result: A total of 10 participants (7 care partners; 3 PLWD) have participated in interviews to date. Themes identified from interviews include: 1.) Outdoor activities help people maintain a sense of identity and connection with their lives before being diagnosed with dementia; 2.) Both a diagnosis of dementia, stage of dementia, and physical changes associated with aging impact on the types of activities people participate in; 3.) Outdoor activities are associated with psychological benefits for PLWD and care partners; 4.) There are unique considerations for PLWD and care partners that need to be considered when designing outdoor spaces or programs for PLWD.Conclusion: Outdoor activities are important to PLWD and care partners and help maintain connections to individuals' identities and are perceived as important to maintaining quality of life. The design of outdoor spaces and activities programs for PLWD and care partners need to incorporate their perspectives to maximize participation and benefits associated with outdoor activities.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S20)
Open AccessExperiences of People Living with Dementia and their Care Partners in Participating in Outdoor Activities
Background: There is increasing evidence for non‐pharmacological interventions to prevent dementia and delay disease progression. Outdoor recreational activities, such as visits to local parks, may help improve behavioural symptoms of dementia, cognition, and quality of life for both people living with dementia (PLWD) and their care partners. However, little is currently known about the experiences of PLWD and care partners about participating in outdoor activities. Understanding their experiences will help inform interventions and policies to promote participation in outdoor activities. Our objectives are to understand the experiences of PLWD and care partners in participating in outdoor activities.Methods: We conducted semi‐structured interviews with PLWD and care partners, either alone or in dyads. Self‐reported characteristics of PLWD and care partners were recorded by online surveys. Interviews were recorded and transcribed for analysis. Interview questions included questions about the following topics: individuals relationships to outdoor activities; how these relationships may have changed over time; their current patterns of outdoor activities; perceived benefits of outdoor activities; potential risks of outdoor activities; and facilitators and barriers to participating in activities. The transcripts of interviews were coded by two independent members of the research team to identify common themes.Result: A total of 10 participants (7 care partners; 3 PLWD) have participated in interviews to date. Themes identified from interviews include: 1.) Outdoor activities help people maintain a sense of identity and connection with their lives before being diagnosed with dementia; 2.) Both a diagnosis of dementia, stage of dementia, and physical changes associated with aging impact on the types of activities people participate in; 3.) Outdoor activities are associated with psychological benefits for PLWD and care partners; 4.) There are unique considerations for PLWD and care partners that need to be considered when designing outdoor spaces or programs for PLWD.Conclusion: Outdoor activities are important to PLWD and care partners and help maintain connections to individuals' identities and are perceived as important to maintaining quality of life. The design of outdoor spaces and activities programs for PLWD and care partners need to incorporate their perspectives to maximize participation and benefits associated with outdoor activities.
- Open Access
- 16 June 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S8)
Development and validation of a dementia risk index for use with administrative healthcare data in Canada
Background: Identification of individuals at high risk for dementia is important for planning health services and targeting prevention strategies. While dementia risk indices are available with clinical data, few have been created for use with population‐based administrative data in Canada. The purpose of this study was to establish a dementia risk index for people aged 50 years and older in Alberta, Canada, utilizing routinely gathered administrative healthcare databases. Using population‐based data, we can better understand the risk of dementia to identify individuals and populations at greatest risk.Method: The study population included all individuals in Alberta, Canada, aged 50 years or older and free of diagnosed dementia on April 1, 2013. Participants were followed for up to 5 years to assess new diagnoses of dementia using a validated algorithm. A total of 59 known measurable dementia risk factors were assessed as potential predictors of dementia. At a 3:2 ratio, the sample was randomly divided into derivation and validation sets. The risk prediction model was created using a Cox proportional hazard model from a list of candidate variables in the derivation sample, and its performance to predict dementia was evaluated in the validation sample.Result: One million participants aged 50 years and older without dementia were included in the study sample (mean age 62.95 years, 50.52% female), and 41,834 (3.86%) individuals developed dementia during follow‐up (mean duration 4.78 years). Out of 59 candidate variables, 17 variables were identified as independent risk factors for dementia, including advanced age, female gender, increased overall medical comorbidity, neighborhood measures of socioeconomic deprivation, specific medical conditions, mental health diagnoses, and measures of health service utilization. The final multivariate Cox proportional hazards model demonstrated good discriminative ability (Harrel’s C‐statistic = 0.87).Conclusion: This risk prediction index, derived using population‐based data, can reliably identify Canadian adults at increased risk of dementia. This risk index may assist clinicians, and the general public in assessing their risks for dementia and facilitate discussions on the most effective ways to reduce this risk. Understanding individual or population‐based dementia risk differences can help design dementia prevention and health promotion programs.
- 16 June 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S8)
Open AccessDevelopment and validation of a dementia risk index for use with administrative healthcare data in Canada
Background: Identification of individuals at high risk for dementia is important for planning health services and targeting prevention strategies. While dementia risk indices are available with clinical data, few have been created for use with population‐based administrative data in Canada. The purpose of this study was to establish a dementia risk index for people aged 50 years and older in Alberta, Canada, utilizing routinely gathered administrative healthcare databases. Using population‐based data, we can better understand the risk of dementia to identify individuals and populations at greatest risk.Method: The study population included all individuals in Alberta, Canada, aged 50 years or older and free of diagnosed dementia on April 1, 2013. Participants were followed for up to 5 years to assess new diagnoses of dementia using a validated algorithm. A total of 59 known measurable dementia risk factors were assessed as potential predictors of dementia. At a 3:2 ratio, the sample was randomly divided into derivation and validation sets. The risk prediction model was created using a Cox proportional hazard model from a list of candidate variables in the derivation sample, and its performance to predict dementia was evaluated in the validation sample.Result: One million participants aged 50 years and older without dementia were included in the study sample (mean age 62.95 years, 50.52% female), and 41,834 (3.86%) individuals developed dementia during follow‐up (mean duration 4.78 years). Out of 59 candidate variables, 17 variables were identified as independent risk factors for dementia, including advanced age, female gender, increased overall medical comorbidity, neighborhood measures of socioeconomic deprivation, specific medical conditions, mental health diagnoses, and measures of health service utilization. The final multivariate Cox proportional hazards model demonstrated good discriminative ability (Harrel’s C‐statistic = 0.87).Conclusion: This risk prediction index, derived using population‐based data, can reliably identify Canadian adults at increased risk of dementia. This risk index may assist clinicians, and the general public in assessing their risks for dementia and facilitate discussions on the most effective ways to reduce this risk. Understanding individual or population‐based dementia risk differences can help design dementia prevention and health promotion programs.
- 1 August 2022
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 23 (11) , 1787-1792.e1
Association Between Long-Term Care Facility Staffing Levels and Antipsychotic Use in US Long-Term Care Facilities
- 1 August 2022
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 23 (11) , 1787-1792.e1
Association Between Long-Term Care Facility Staffing Levels and Antipsychotic Use in US Long-Term Care Facilities